2-amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(tetrahydro-2H-pyran-4-yl)pyrido[2,3-d]pyrimidin-7(8H)-one

ID: ALA3218404

Chembl Id: CHEMBL3218404

PubChem CID: 59258894

Max Phase: Preclinical

Molecular Formula: C19H21N5O3

Molecular Weight: 367.41

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2cc3c(C)nc(N)nc3n(C3CCOCC3)c2=O)cn1

Standard InChI:  InChI=1S/C19H21N5O3/c1-11-14-9-15(12-3-4-16(26-2)21-10-12)18(25)24(13-5-7-27-8-6-13)17(14)23-19(20)22-11/h3-4,9-10,13H,5-8H2,1-2H3,(H2,20,22,23)

Standard InChI Key:  KXSMKVQEHUCHOE-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3218404

   2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(oxan-4-yl)pyrido[2,3-d]pyrimidin-7-one

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 367.41

Molecular Weight (Monoisotopic): 367.1644

AlogP: 2.10

#Rotatable Bonds: 3

Polar Surface Area: 105.15

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 3.70

CX LogP: 0.96

CX LogD: 0.96

Aromatic Rings: 3

Heavy Atoms: 27

QED Weighted: 0.76

Np Likeness Score: -1.12

References

1. Cheng H, Bagrodia S, Bailey S, Edwards M, Hoffman J, Hu Q, Kania R, Knighton DR, Marx MA, Ninkovic S, Sun S, Zhang E.  (2010)  Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design,  1  (2): [10.1039/C0MD00072H]

2.  (2014)  4-methylpyridopyrimidinone compounds, 

Source

Source(2):

• Scientific Literature
• BindingDB Database